Company / Free Cash Flow per Share
Twist Bioscience Corp Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.26
FY2025
5-year range
-$4.20 / -$1.19
FY2021-FY2025
Trend
-6.1%
vs FY2024
Sector context
#108 of 190
Health Care
What the data says
At $-1.26, Twist Bioscience Corp's free cash flow per share ranks #108 of 190 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-25009.67 in FY2018 to $-0.02 in FY2017.
Based on SEC 10-K filings.
-1.26 in FY2025.
Improved from $-2.99 to $-1.26 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#108 of 190 in Health CareTop 57% of 190This company -$1.26 Sector average $3.32
▼
-138.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 6.1% year-over-year.
- Ranks #108 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.26 | -6.1% |
| FY2024 | -$1.19 | +60.2% |
| FY2023 | -$2.99 | +28.7% |
| FY2022 | -$4.20 | -45.4% |
| FY2021 | -$2.89 | +25.6% |
| FY2020 | -$3.88 | -3.8% |
| FY2019 | -$3.74 | +100.0% |
| FY2018 | -$25009.67 | -104636726.8% |
| FY2017 | -$0.02 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026